8 vaccines, 4 treatments in India's COVID-19 arsenal

The Central Drugs Standard Control Organisation has granted restricted emergency use authorisation to two new vaccines and a drug for COVID-19, taking the number of preventives and treatments......

Covid vaccines for children likely by Sept: AIIMS chief

Trials for Bharat Biotech's Covid-19 vaccine Covaxin on children are underway and results are expected to be released by September, All India Institute of Medical Sciences director Randeep Guleria......

Govt developing multi-variant Covid-19 vaccine

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus,......

3rd wave: Govt creating 30-day stock of key Covid medicines

'The Centre is planning to procure five million vials of Remdesivir ahead of the third wave. What’s better is that this time, the government is paying us in advance,' said a senior executive......

Cadila plans captive units in PhaEZ Park

Cadila Pharmaceuticals has chalked out ambitious plans to set up close to eight units in its upcoming PhaEZ Park near Ahmedabad, which is touted to be the largest in India. "In all, we will invest......

Gujarat pharma hub hit by near-zero exports

With the government asking the companies to operate with only 50 per cent staff strength, and exports dipping to almost zero, the truck and bus drivers idling at the petrol pump say they hardly......

Cadila believes it has silver bullet to fight COVID-19

Can Interferon alfa-2b treat COVID-19 effectively?Sohini Dutt reports. Kindly note the image has been posted only for representational purposes. Photograph: PTI Photo Ahmedabad-based......

Cadila to market anti-cancer drug by 2006

Cadila Pharmaceuticals Ltd on Monday said it would market anti-cancer drugs GCS (Granulocyte Colony Stimulating) Factor and GMCS (Granulocyte Macrophage Colony Stumating) Factor by 2006 end."The......